JUL 14, 2020 7:00 AM PDT

Cancer Genomics: What We Can Learn from Africa

Speaker
  • Vincent L. Gregory, Jr. Professor of Cancer Prevention, Harvard TH Chan School of Public Health and Division of Population Sciences, Dana Farber Cancer Institute
    BIOGRAPHY

Abstract
DATE:  July 14, 2020
TIME:   7:00 am PDT, 10:00 am EDT
 
This is the second topic in the webinar series on ‘Predictive Genomics for Population & Personalized Health’.
 
Cancer is a growing burden in Africa.  By 2040, it is estimated that cancer incidence will more than double in Sub-Saharan Africa, and that more than twice as many cancer deaths will occur in low- and middle-income countries compared to upper-income countries.  While the majority of cancer cases in the US and Europe are diagnosed at an early (treatable) stage, the majority of African cancer cases are and will likely continue to be diagnosed at late (often untreatable) stages.  Therefore, cancer represents a significant and under-appreciated public health problem in Africa.  We have developed the Men of African Descent and Carcinoma of the Prostate (MADCaP, www.madcapnetwork.org) to address this emerging public health issue.  MADCaP is undertaking research to 1) evaluate African ancestral relationships among African populations, 2) understand the relationship of ancestry with cancer etiology, and 3) understand the role of genetic and non-genetic factors in cancer etiology and aggressiveness.  We have established the laboratory, clinical, and epidemiological infrastructure to undertake these studies.  We have demonstrated that ancestry and candidate genes are associated with genetic susceptibility to cancer.  Therefore, optimal prediction of cancer risk and outcomes may require race-specific marker panels including polygenic risk scores. By expanding the research infrastructure and capabilities of these consortia, we will address an important and increasing cancer problem in Africa, and we will build capacity for research in an underserved continent. In addition, the increase in knowledge about genomic diversity will inform cancer risk, prevention, and treatment for all populations. 
 
Learning Objectives:
  • Review the role of genetic and non-genetic factors in cancer etiology and aggressiveness
  • Design content modules in a population-specific array
  • Develop polygenic risk scores (PRS) for a specific disease in a specific population
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

 


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
MAY 18, 2021 8:00 AM PDT
C.E. CREDITS
MAY 18, 2021 8:00 AM PDT
Date: May 18, 2021 Time: 8:00am (PST) The global pandemic has caused an increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide qu...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
Loading Comments...
Show Resources